PENTASA SLOW RELEASE TABLETS 500 MG Israel - English - Ministry of Health

pentasa slow release tablets 500 mg

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 500 mg - mesalazine - mesalazine - mild to moderate ulcerative colitis.crohn's disease

PENTASA SLOW RELEASE GRANULES 2 G Israel - English - Ministry of Health

pentasa slow release granules 2 g

ferring pharmaceuticals ltd - mesalazine - granules - mesalazine 2 g/sachet - mesalazine - mesalazine - mild to moderate ulcerative colitis or crohn's disease.

PENTASA SLOW RELEASE TABLETS 1 GRAM Israel - English - Ministry of Health

pentasa slow release tablets 1 gram

ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mesalazine - mild to moderate ulcerative colitis. crohn's disease.

EVICEL HUMAN SURGICAL SEALANT Israel - English - Ministry of Health

evicel human surgical sealant

omrix biopharmaceuticals ltd, israel - calcium chloride; protein clottable; thrombin - solution - thrombin 800 - 1200 iu / 1 ml; calcium chloride 5.6 - 6.20 mg / 1 ml; protein clottable 50 - 90 mg / 1 ml - combinations - combinations - general haemostasis : evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. efficacy has been demonstrated in liver surgery and orthopaedic surgery.evicel ® is also indicated as suture support for haemostasis for suture line sealing in dura mater closure.

POLYCUTAN Israel - English - Ministry of Health

polycutan

padagis israel pharmaceuticals ltd, israel - clotrimazole; dexamethasone acetate; neomycin sulfate - cream - clotrimazole 1 %; neomycin sulfate 0.645 %; dexamethasone acetate 0.044 % - combinations - combinations - treatment of dermatitis involving also a bacterial and/or fungal infection.

KALETRA ORAL SOLUTION Israel - English - Ministry of Health

kaletra oral solution

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

KALETRA 100 MG25 MG TABLETS Israel - English - Ministry of Health

kaletra 100 mg25 mg tablets

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - lopinavir 100 mg; ritonavir 25 mg - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infections.

KALETRA  200 MG50 MG TABLETS Israel - English - Ministry of Health

kaletra 200 mg50 mg tablets

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

KALETRA  200 MG50 MG TABLETS Israel - English - Ministry of Health

kaletra 200 mg50 mg tablets

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - film coated tablets - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

TRISENOX Israel - English - Ministry of Health

trisenox

medison pharma ltd - arsenic trioxide - solution for injection - arsenic trioxide 1 mg/ml - arsenic trioxide - arsenic trioxide - trisenox is indicated for induction of remission, and consolidation in adult patients with:• newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (apl) (white blood cell count, ≤ 10 x 1000/μl) in combination with all-trans-retinoic acid (atra)• relapsed/refractory acute promyelocytic leukaemia (apl)(previous treatment should have included a retinoid and chemotherapy) characterised by the presence of the t(15;17) translocation and/or the presence of the pro-myelocytic leukaemia/retinoic-acid-receptor-alpha (pml/rar-alpha) gene.the response rate of other acute myelogenous leukaemia subtypes to arsenic trioxide has not been examined.